Response to Chiasson et al.: Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

✍ Scribed by P. T. Sawicki; T. Kaiser

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 106 KB
• Volume: 47
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-004-1410-y